Price Momentum and Recent Market Performance
As of 28 Jul 2026, Jubilant Ingrevia’s stock price closed at ₹743.15, marking a 2.43% increase from the previous close of ₹725.50. The intraday range saw a low of ₹725.50 and a high of ₹755.00, indicating a relatively volatile trading session. The stock remains below its 52-week high of ₹845.95 but comfortably above its 52-week low of ₹535.30, reflecting a recovery phase within the year.
When compared to the broader market, Jubilant Ingrevia has outperformed the Sensex over several time frames. Notably, the stock delivered a robust 19.58% return over the past month, while the Sensex declined marginally by 0.34%. Year-to-date, the stock has gained 5.56%, contrasting with the Sensex’s 9.84% loss. Over a three-year horizon, Jubilant Ingrevia’s return of 75.54% significantly outpaces the Sensex’s 15.95%, underscoring its strong medium-term performance despite a slight 5.3% decline over the last year.
Technical Indicator Analysis: Mixed Signals
The technical landscape for Jubilant Ingrevia is complex, with several indicators offering divergent views. The Moving Average Convergence Divergence (MACD) indicator shows a bullish signal on the weekly chart, suggesting positive momentum in the short term. However, the monthly MACD is mildly bearish, indicating some longer-term caution among investors.
The Relative Strength Index (RSI), a momentum oscillator, currently shows no definitive signal on both weekly and monthly timeframes, implying that the stock is neither overbought nor oversold. This neutral RSI reading suggests that the stock’s price movement may consolidate before a decisive trend emerges.
Bollinger Bands, which measure volatility and potential price breakouts, are bullish on both weekly and monthly charts. This indicates that the stock price is trending towards the upper band, often a sign of upward momentum and potential continuation of gains.
Moving Averages and Trend Assessment
On the daily chart, moving averages are bullish, reinforcing the short-term positive momentum. This aligns with the weekly MACD and Bollinger Bands signals, suggesting that the stock may continue to experience upward price pressure in the near term.
However, the Know Sure Thing (KST) indicator, which is a momentum oscillator used to identify major stock market cycles, is mildly bearish on both weekly and monthly charts. This divergence between KST and other indicators highlights the possibility of a cautious outlook among longer-term investors.
Dow Theory analysis reveals no clear trend on the weekly timeframe but indicates a mildly bullish trend on the monthly scale. This mixed reading further emphasises the transitional phase the stock is currently undergoing.
On-Balance Volume (OBV), a volume-based indicator that measures buying and selling pressure, shows no trend on the weekly chart but is bullish on the monthly chart. This suggests that while short-term volume activity is indecisive, longer-term accumulation may be supporting the stock price.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Mojo Score and Rating Upgrade
Jubilant Ingrevia currently holds a Mojo Score of 61.0, reflecting a moderate level of confidence in its fundamentals and technical outlook. The company’s Mojo Grade was upgraded from Sell to Hold on 8 Jun 2026, signalling an improvement in its overall investment appeal. This upgrade aligns with the recent technical trend shift from bullish to mildly bullish, indicating a more cautious but positive stance among analysts.
As a small-cap entity within the specialty chemicals sector, Jubilant Ingrevia’s market capitalisation grade remains classified as small-cap, which typically entails higher volatility but also greater growth potential compared to large-cap peers.
Sector Context and Comparative Performance
Within the specialty chemicals sector, Jubilant Ingrevia’s recent price momentum and technical signals suggest it is navigating a phase of consolidation with potential for further upside. The sector itself has been subject to cyclical pressures, but companies demonstrating consistent earnings growth and technical resilience are attracting investor interest.
Comparing Jubilant Ingrevia’s returns to the Sensex over various periods reveals a stock that has outperformed the benchmark in the short to medium term, particularly over one month (+19.58% vs. -0.34%) and three years (+75.54% vs. +15.95%). However, the stock’s five-year return of 20.07% trails the Sensex’s 46.13%, indicating some periods of underperformance that investors should consider.
Is Jubilant Ingrevia Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Investor Takeaway and Outlook
Jubilant Ingrevia’s current technical profile suggests a stock in transition, with short-term bullish momentum tempered by some longer-term caution. The bullish daily moving averages and weekly MACD indicate potential for continued price appreciation in the near term, supported by positive Bollinger Bands readings on multiple timeframes.
However, the mildly bearish monthly MACD and KST indicators, alongside neutral RSI signals, counsel prudence. Investors should monitor these indicators closely for confirmation of a sustained trend or signs of reversal.
The stock’s recent outperformance relative to the Sensex and its upgrade to a Hold rating by MarketsMOJO reinforce its appeal as a candidate for selective accumulation, particularly for those with a medium-term investment horizon. Nevertheless, the small-cap nature of Jubilant Ingrevia warrants attention to volatility and sector-specific risks.
Overall, Jubilant Ingrevia appears positioned for measured gains, with technical indicators suggesting a cautiously optimistic outlook. Investors seeking exposure to the specialty chemicals sector may find this stock a viable option, provided they remain vigilant to evolving technical signals and broader market conditions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
